Trials / Unknown
UnknownNCT03559322
Real World Experiences of the iNAP® Lite in OSA Adults in Taiwan
A Prospective, Observational, Post-market Surveillance Study to Evaluate the Long-term Safety and Efficacy of the iNAP® Sleep Therapy System in Adults With Obstructive Sleep Apnea
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 76 (estimated)
- Sponsor
- Somnics, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A Prospective, Observational, Post-market Surveillance Study to Evaluate the Long-term Safety and Efficacy of the iNAP® Lite Sleep Therapy System in Adults with Obstructive Sleep Apnea
Detailed description
Obstructive sleep apnea (OSA) impacts sleep quality of patients, which contributes significantly to hypertension, stroke, myocardial infarction and other health problems. Intraoral devices, such as tongue retaining devices, palatal lifting devices and mandibular repositioning devices designed to increase the patency of the airway and to decrease airway obstruction, are used to treat OSA. To this end, we are conducting a prospective, observational, post-market surveillance study to evaluate the long-term safety and efficacy of the iNAP® Lite sleep therapy system (iNAP® Lite), a tongue and soft palate retaining intraoral device, in adults with OSA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | iNAP® Lite Sleep Therapy System | Class II intraoral devices for snoring and/or obstructive sleep apnea |
Timeline
- Start date
- 2019-08-01
- Primary completion
- 2021-08-01
- Completion
- 2021-12-30
- First posted
- 2018-06-18
- Last updated
- 2019-09-23
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT03559322. Inclusion in this directory is not an endorsement.